SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-008353
Filing Date
2016-09-14
Accepted
2016-09-14 09:14:33
Documents
64
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gemp-20160630x10q.htm 10-Q 1567092
2 EX-31.1 gemp-20160630ex31169b594.htm EX-31.1 17595
3 EX-31.2 gemp-20160630ex312e13b28.htm EX-31.2 17673
4 EX-32.1 gemp-20160630ex3216454ec.htm EX-32.1 12013
  Complete submission text file 0001558370-16-008353.txt   5003605

Data Files

Seq Description Document Type Size
5 EX-101.INS gemp-20160630.xml EX-101.INS 710962
6 EX-101.SCH gemp-20160630.xsd EX-101.SCH 46083
7 EX-101.CAL gemp-20160630_cal.xml EX-101.CAL 32682
8 EX-101.DEF gemp-20160630_def.xml EX-101.DEF 197115
9 EX-101.LAB gemp-20160630_lab.xml EX-101.LAB 406653
10 EX-101.PRE gemp-20160630_pre.xml EX-101.PRE 330390
Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 161884283
SIC: 2834 Pharmaceutical Preparations